Penbrook Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.32M Buy
11,370
+5,610
+97% +$652K 0.5% 49
2025
Q1
$642K Hold
5,760
0.49% 47
2024
Q4
$561K Hold
5,760
0.38% 56
2024
Q3
$663K Hold
5,760
0.43% 50
2024
Q2
$613K Hold
5,760
0.37% 56
2024
Q1
$557K Hold
5,760
0.35% 64
2023
Q4
$582K Buy
5,760
+300
+5% +$30.3K 0.39% 58
2023
Q3
$556K Hold
5,460
0.41% 54
2023
Q2
$551K Hold
5,460
0.4% 55
2023
Q1
$502K Hold
5,460
0.38% 61
2022
Q4
$495K Sell
5,460
-1,000
-15% -$90.7K 0.42% 63
2022
Q3
$491K Hold
6,460
0.42% 61
2022
Q2
$546K Hold
6,460
0.43% 63
2022
Q1
$567K Hold
6,460
0.37% 68
2021
Q4
$565K Hold
6,460
0.34% 73
2021
Q3
$528K Hold
6,460
0.33% 78
2021
Q2
$589K Hold
6,460
0.35% 72
2021
Q1
$552K Sell
6,460
-300
-4% -$25.6K 0.4% 69
2020
Q4
$638K Hold
6,760
0.49% 59
2020
Q3
$588K Hold
6,760
0.51% 55
2020
Q2
$590K Hold
6,760
0.58% 53
2020
Q1
$557K Hold
6,760
0.71% 40
2019
Q4
$640K Hold
6,760
0.62% 56
2019
Q3
$587K Buy
6,760
+260
+4% +$22.6K 0.64% 57
2019
Q2
$594K Buy
6,500
+362
+6% +$33.1K 0.64% 54
2019
Q1
$529K Hold
6,138
0.55% 64
2018
Q4
$472K Hold
6,138
0.54% 59
2018
Q3
$474K Hold
6,138
0.45% 70
2018
Q2
$415K Hold
6,138
0.4% 78
2018
Q1
$445K Hold
6,138
0.44% 73
2017
Q4
$462K Buy
+6,138
New +$462K 0.42% 74
2016
Q3
$434K Hold
6,138
0.47% 70
2016
Q2
$454K Hold
6,138
0.5% 68
2016
Q1
$398K Hold
6,138
0.44% 74
2015
Q4
$473K Hold
6,138
0.49% 70
2015
Q3
$506K Hold
6,138
0.54% 67
2015
Q2
$541K Buy
6,138
+335
+6% +$29.5K 0.51% 71
2015
Q1
$513K Hold
5,803
0.46% 78
2014
Q4
$482K Hold
5,803
0.43% 84
2014
Q3
$489K Hold
5,803
0.45% 79
2014
Q2
$471K Sell
5,803
-5,803
-50% -$471K 0.42% 80
2014
Q1
$860K Buy
11,606
+5,803
+100% +$430K 0.41% 75
2013
Q4
$418K Buy
+5,803
New +$418K 0.41% 78